Velasco Puyó, PabloTagarro García, AlfredoGarcía Obregón, SusanaVillate, OlatzMoraleda, CintaHuerta Aragonés, JorgeBardón Cancho, Eduardo J.Faura Morros, AnnaGalán Gómez, VíctorEscobar Fernández, Lauraet al.2025-07-262025-07-262024Velasco Puyó, P., Tagarro, A., Garcia‐Obregon, S., Villate, O., Moraleda, C., Huerta Aragonés, J., Bardón Cancho, E. J., Faura Morros, A., Galán‐Gómez, V., Escobar Fernández, L., Lendinez‐Molinos, F., Herrero Velasco, B., Ureña Horno, L., Domínguez‐Pinilla, N., Pascual Gazquez, J. F., Nova Lozano, C., Osuna‐Marco, M., Marín‐Cruz, I., Gomez Pastrana, I., … EPICO‐AEP Working Group. (2024). Cancer is not a risk factor for severe COVID‐19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities. Pediatric Blood & Cancer, 71(8). https://doi.org/10.1002/pbc.311201545-50091545-5017https://hdl.handle.net/11268/16044TheEPICO(SpanishgeneralregistryofCOVID-19inchildren)-SEHOP(SpanishSocietyofPediatricHematologyandOncology)platformgathersdatafromchildrenwith SARS-CoV-2inSpain,allowingcomparisonbetweenchildrenwithcancerorallogeneic hematopoieticstemcelltransplantation(alloHSCT)andthosewithout.Theinfection ismilderinthecancer/alloHSCTgroupthaninchildrenwithoutcomorbidities(7.1% vs.14.7%), except inchildrenwithrecentalloHSCT(lessthan300days),ofwhich 35.7%experiencedsevereCOVID-19.ThesedatahavebeensharedwiththeSEHOP memberstosupporttreatmentandisolationpoliciesakintothoseforchildrenwithoutcancer,exceptforthosewithrecentalloHSCToradditionalcomorbidities.This highlightsthecollaborativeregistriespotentialinmanagingpandemicemergencies.engPediatríaOncología Médicajournal article10.1002/pbc.31120embargoed accessCiencias médicasPediatríaCáncerGoal 3: Ensure healthy lives and promote well-being for all at all ages